Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Virology ; 578: 7-12, 2023 01.
Article in English | MEDLINE | ID: mdl-36434906

ABSTRACT

Many plant virus-like particles (VLPs) utilized in nanotechnology are 30-nm icosahedrons. To expand the VLP platforms, we produced VLPs of Cytoplasmic type citrus leprosis virus (CiLV-C) in Nicotiana benthamiana. We were interested in CiLV-C because of its unique bacilliform shape (60-70 nm × 110-120 nm). The CiLV-C capsid protein (p29) gene was transferred to the pTRBO expression vector transiently expressed in leaves. Stable VLPs were formed, as confirmed by agarose gel electrophoresis, transmission electron microscopy and size exclusion chromatography. Interestingly, the morphology of the VLPs (15.8 ± 1.3 nm icosahedral particles) differed from that of the native bacilliform particles indicating that the assembly of native virions is influenced by other viral proteins and/or the packaged viral genome. The smaller CiLV-C VLPs will also be useful for structure-function studies to compare with the 30-nm icosahedrons of other VLPs.


Subject(s)
Citrus , RNA Viruses , Rhabdoviridae , Molecular Farming , RNA Viruses/genetics , Virion/genetics
2.
Nat Rev Mater ; 7(5): 372-388, 2022.
Article in English | MEDLINE | ID: mdl-34900343

ABSTRACT

Biologics - medications derived from a biological source - are increasingly used as pharmaceuticals, for example, as vaccines. Biologics are usually produced in bacterial, mammalian or insect cells. Alternatively, plant molecular farming, that is, the manufacture of biologics in plant cells, transgenic plants and algae, offers a cheaper and easily adaptable strategy for the production of biologics, in particular, in low-resource settings. In this Review, we discuss current vaccination challenges, such as cold chain requirements, and highlight how plant molecular farming in combination with advanced materials can be applied to address these challenges. The production of plant viruses and virus-based nanotechnologies in plants enables low-cost and regional fabrication of thermostable vaccines. We also highlight key new vaccine delivery technologies, including microneedle patches and material platforms for intranasal and oral delivery. Finally, we provide an outlook of future possibilities for plant molecular farming of next-generation vaccines and biologics.

4.
Nat Commun ; 12(1): 613, 2021 01 27.
Article in English | MEDLINE | ID: mdl-33504774

ABSTRACT

Induction of intrinsic liver regeneration is an unmet need that can be achieved by temporally activating key hepatocyte regenerative pathways. Here, we establish an efficient, safe, non-integrative method to transiently express hepatocyte-growth-factor (HGF) and epidermal-growth-factor (EGF) in hepatocytes via nucleoside-modified, lipid-nanoparticle-encapsulated mRNA (mRNA-LNP) delivery in mice. We confirm specific hepatotropism of mRNA-LNP via intravenous injection of firefly luciferase encoding mRNA-LNP, with protein expression lasting about 3 days. In the liver, virtually all hepatocytes are transfected along with a subpopulation of endothelial and Kupffer cells. In homeostasis, HGF mRNA-LNP efficiently induce hepatocyte proliferation. In a chronic liver injury mouse model recapitulating non-alcoholic fatty liver disease, injections of both HGF and EGF mRNA-LNP sharply reverse steatosis and accelerate restoration of liver function. Likewise, HGF and EGF mRNA-LNP accelerate liver regeneration after acetaminophen-induced acute liver injury with rapid return to baseline ALT levels. This study introduces mRNA-LNP as a potentially translatable safe therapeutic intervention to harness liver regeneration via controlled expression of endogenous mitogens in vivo.


Subject(s)
Hepatocytes/pathology , Lipids/chemistry , Liver Regeneration/physiology , Liver/pathology , Nanoparticles/chemistry , Nucleosides/metabolism , RNA, Messenger/metabolism , Acetaminophen , Animals , Cell Proliferation/drug effects , Chronic Disease , Disease Models, Animal , Epidermal Growth Factor/pharmacology , Female , Green Fluorescent Proteins/metabolism , Hepatocyte Growth Factor/pharmacology , Hepatocytes/drug effects , Homeostasis/drug effects , Injections , Liver/drug effects , Liver/injuries , Liver/physiopathology , Liver Function Tests , Liver Regeneration/drug effects , Mice, Inbred C57BL
5.
Microbiol Mol Biol Rev ; 85(1)2021 02 17.
Article in English | MEDLINE | ID: mdl-33441488

ABSTRACT

The P2X7 receptor (P2RX7) is an important molecule that functions as a danger sensor, detecting extracellular nucleotides from injured cells and thus signaling an inflammatory program to nearby cells. It is expressed in immune cells and plays important roles in pathogen surveillance and cell-mediated responses to infectious organisms. There is an abundance of literature on the role of P2RX7 in inflammatory diseases and the role of these receptors in host-pathogen interactions. Here, we describe the current knowledge of the role of P2RX7 in the host response to a variety of pathogens, including viruses, bacteria, fungi, protozoa, and helminths. We describe in vitro and in vivo evidence for the critical role these receptors play in mediating and modulating immune responses. Our observations indicate a role for P2X7 signaling in sensing damage-associated molecular patterns released by nearby infected cells to facilitate immunopathology or protection. In this review, we describe how P2RX7 signaling can play critical roles in numerous cells types in response to a diverse array of pathogens in mediating pathogenesis and immunity to infectious agents.


Subject(s)
Host-Pathogen Interactions/immunology , Receptors, Purinergic P2X7/immunology , Signal Transduction/immunology , Alarmins/immunology , Animals , Bacteria/immunology , Fungi/immunology , Helminths/immunology , Host-Pathogen Interactions/physiology , Humans , Inflammation/immunology , Parasites/immunology , Viruses/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...